Syllabus: GS3/Economy
Context
- Union Minister of Science & Technology called for a wider public understanding and inclusive participation in India’s biotechnology mission, stating that every Indian is a stakeholder in the country’s bioeconomy.
- The Minister reiterated the government’s commitment to realizing a $300 billion bioeconomy by 2030.
What is Bioeconomy?
- The bioeconomy is the use of renewable biological resources to produce food, energy and industrial goods, which supports sustainability and economic growth.
- Innovations like gene editing and bioprinting are driving progress, while integration across sectors strengthens long-term impact.
- By aligning biotechnology with digital tools and circular economy principles, the bioeconomy offers sustainable solutions to environmental challenges and promotes overall societal well-being.
India’s Bioeconomy
- India is among the Top 12 destinations for biotechnology worldwide and 3rd largest destination for biotechnology in Asia Pacific.
- India’s bioeconomy has grown sixteen-fold from $10 billion in 2014 to an impressive $165.7 billion in 2024.
- Contributing 4.25% to the national GDP, the sector has demonstrated a robust compound annual growth rate (CAGR) of 17.9% over the past four years.
- India’s Biotechnology sector is categorised into Biopharmaceuticals, Bio agriculture, Bio IT and Bio Services.
- Future Goals: Target of achieving a $300 billion bioeconomy by 2030.
- India also seeks to lead globally in bio-pharma, including vaccines, diagnostics, and therapeutics.
Government Initiatives and Key Programmes
- BioE3 Policy (Biotechnology for Economy, Environment, and Employment): It was approved by the Union Cabinet in 2024, and aims to transform India into a global biotech powerhouse by fostering high-performance biomanufacturing. Key features of the policy include:
- Innovation-driven support for R&D and entrepreneurship;
- Establishment of Biomanufacturing & Bio-AI hubs and Biofoundry;
- Focus on regenerative bioeconomy models for green growth;
- Expansion of India’s skilled workforce;
- Alignment with ‘Net Zero’ carbon economy and ‘Lifestyle for Environment’ (LiFE) initiatives.
- National Biopharma Mission: It is a government-approved initiative led by the Department of Biotechnology (DBT) and implemented by BIRAC.
- Aim: To boost India’s capabilities in biopharmaceuticals, vaccines, biosimilars, medical devices, and diagnostics by fostering collaboration between industry and academia.
- With a budget of $250 million, co-funded 50% by the World Bank, the mission supports 101 projects, involving over 150 organisations and 30 MSMEs.
| Key Achievements in India’s Pharma Sector: – India has emerged as a global hub for affordable, high-quality medicines, ranking 3rd in pharmaceutical production by volume and 14th by value. – Produces 65% of the world’s vaccines, significantly benefiting low- and middle-income countries. – India is working on the first indigenous HPV vaccine to prevent cervical cancer in adolescent girls. – Every third tablet consumed globally is manufactured in India, demonstrating global trust in Indian pharma. |
- Bio-agriculture: Agricultural biotechnology in India is advancing rapidly through innovations in genomics, transgenics, and gene editing under the Department of Biotechnology’s Agriculture Biotechnology programme.
- Climate-Smart Crops: A drought-tolerant, high-yielding chickpea variety SAATVIK (NC 9) has been approved for cultivation.
- Genome-Edited Rice: Loss-of-function mutations in yield-limiting genes have led to improved rice lines like DEP1-edited MTU-1010, showing higher yields.
- Genotyping Arrays: India’s first 90K SNP arrays—IndRA for rice and IndCA for chickpea—enable DNA fingerprinting and variety identification.
- Amaranth Resources: A genomic database, NIRS techniques, and a 64K SNP chip aid nutritional screening and development of anti-obesity amaranth varieties.
- Biocontrol: A nano-formulation from Myrothecium verrucaria offers eco-friendly control of powdery mildew in tomato and grape.
- Kisan-Kavach: An anti-pesticide protective suit enhances farmer safety from toxic exposure.
- Biotech-KISAN (Biotech-Krishi Innovation Science Application Network): Biotech-KISAN is a scientist-farmer partnership programme launched to empower farmers through agricultural innovation and scientific interventions.
- It follows a hub-and-spoke model and is active across 115 Aspirational Districts in India.
- Bioenergy: Bioenergy is a form of renewable energy that is derived from recently living organic materials known as biomass, which can be used to produce transportation fuels, heat, electricity, and products.
- Ethanol blending has seen a significant rise—from 1.53% in 2014 to 15% in 2024, with a target of 20% blending by 2025.
- This shift has not only reduced crude oil imports by 173 lakh metric tons but also saved Rs. 99,014 crores in foreign exchange and cut 519 lakh metric tons of CO₂ emissions.
- Boosting Biotech Innovation Through BIRAC Initiatives: The Biotechnology Industry Research Assistance Council (BIRAC), established by the Department of Biotechnology in 2012, plays a pivotal role in nurturing India’s biotech startup ecosystem.
- With 95 bio-incubation centres set up nationwide, BIRAC supports startups through funding, infrastructure, and mentorship.
Way Ahead
- India’s bioeconomy stands at a defining moment, with its integrated approach to innovation, sustainability, and inclusive development setting a global benchmark.
- Through robust policy frameworks, cutting-edge research, and a strong emphasis on collaboration across sectors, the nation is well on track to redefine its industrial and environmental landscape.
- The convergence of bio-manufacturing, bio-agriculture, and bioenergy not only strengthens national resilience but also signals India’s strategic intent to lead in the emerging global bioeconomy.
Source: PIB
Next article
News In Short-08-07-2025
